{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:33:23Z","timestamp":1767152003052,"version":"build-2238731810"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/bmt.2013.111","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T06:38:34Z","timestamp":1376289514000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL"],"prefix":"10.1038","volume":"49","author":[{"given":"M","family":"Eefting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J M","family":"Halkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L C","family":"de Wreede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kersting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E W A","family":"Marijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"von dem Borne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H F","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,12]]},"reference":[{"key":"BFbmt2013111_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3324\/haematol.2012.063602","volume":"98","author":"D Pulte","year":"2012","unstructured":"Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M . Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of minority patients. Haematologica 2012; 98: 222\u2013229.","journal-title":"Haematologica"},{"key":"BFbmt2013111_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbmt.2012.09.003","volume":"19","author":"JD Goldberg","year":"2012","unstructured":"Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN et al. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biol Blood Marrow Transplant 2012; 19: 208\u2013213.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2013111_CR3","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1002\/cncr.25136","volume":"116","author":"R Ram","year":"2010","unstructured":"Ram R, Gafter-Gvili A, Vidal L, Paul M, Ben-Bassat I, Shpilberg O et al. Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis. Cancer 2010; 116: 3447\u20133457.","journal-title":"Cancer"},{"key":"BFbmt2013111_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.seminhematol.2007.08.004","volume":"44","author":"R Willemze","year":"2007","unstructured":"Willemze R, Labar B . Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Semin Hematol 2007; 44: 267\u2013273.","journal-title":"Semin Hematol"},{"key":"BFbmt2013111_CR5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/cncr.21932","volume":"106","author":"M Yanada","year":"2006","unstructured":"Yanada M, Matsuo K, Suzuki T, Naoe T . Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer 2006; 106: 2657\u20132663.","journal-title":"Cancer"},{"key":"BFbmt2013111_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 2008; 111: 1827\u20131833.","journal-title":"Blood"},{"key":"BFbmt2013111_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1182\/blood-2012-07-445098","volume":"121","author":"V Gupta","year":"2012","unstructured":"Gupta V, Richards S, Rowe J . Allogeneic, but not autologous, hematopoietic-cell-transplant improves survival only among younger adults with acute lymphoblastic leukemia in first remission: individual-patient-data meta-analysis. Blood 2012; 121: 339\u2013350.","journal-title":"Blood"},{"key":"BFbmt2013111_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3324\/haematol.2011.048348","volume":"96","author":"JM Ribera","year":"2011","unstructured":"Ribera JM . Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how. Haematologica 2011; 96: 1083\u20131086.","journal-title":"Haematologica"},{"key":"BFbmt2013111_CR9","first-page":"53","volume":"1","author":"JF Apperley","year":"1986","unstructured":"Apperley JF, Jones L, Hale G, Waldmann H, Hows J, Rombos Y et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1986; 1: 53\u201366.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2013111_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1200\/JCO.1998.16.3.931","volume":"16","author":"DI Marks","year":"1998","unstructured":"Marks DI, Bird JM, Cornish JM, Goulden NJ, Jones CG, Knechtli CJ et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 931\u2013936.","journal-title":"J Clin Oncol"},{"key":"BFbmt2013111_CR11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/sj.leu.2402203","volume":"15","author":"N Schaap","year":"2001","unstructured":"Schaap N, Schattenberg A, Bar B, Preijers F, van de Wiel van Kemenade E, de Witte T . Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions. Leukemia 2001; 15: 1339\u20131346.","journal-title":"Leukemia"},{"key":"BFbmt2013111_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1703659","volume":"30","author":"M Miglino","year":"2002","unstructured":"Miglino M, Berisso G, Grasso R, Canepa L, Clavio M, Pierri I et al. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse. Bone Marrow Transplant 2002; 30: 579\u2013585.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2013111_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/bmt.2009.177","volume":"45","author":"Y Chalandon","year":"2010","unstructured":"Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP et al. Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant 2010; 45: 558\u2013564.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2013111_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2013111_CR15","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.0530192100","volume":"100","author":"WA Marijt","year":"2003","unstructured":"Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742\u20132747.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2013111_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.leukres.2008.03.031","volume":"33","author":"M Tiribelli","year":"2009","unstructured":"Tiribelli M, Sperotto A, Candoni A, Simeone E, Buttignol S, Fanin R . Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib. Leuk Res 2009; 33: 174\u2013177.","journal-title":"Leuk Res"},{"key":"BFbmt2013111_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","volume":"114","author":"J Pidala","year":"2009","unstructured":"Pidala J, Anasetti C, Jim H . Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009; 114: 7\u201319.","journal-title":"Blood"},{"key":"BFbmt2013111_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","volume":"29","author":"R Bassan","year":"2011","unstructured":"Bassan R, Hoelzer D . Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 2011; 29: 532\u2013543.","journal-title":"J Clin Oncol"},{"key":"BFbmt2013111_CR19","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","volume":"109","author":"A de Labarthe","year":"2007","unstructured":"de Labarthe A, Rousselot P, Huguet-Rigal F, Delabesse E, Witz F, Maury S et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 2007; 109: 1408\u20131413.","journal-title":"Blood"},{"key":"BFbmt2013111_CR20","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1182\/blood-2004-09-3785","volume":"105","author":"S Lee","year":"2005","unstructured":"Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW et al. The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 2005; 105: 3449\u20133457.","journal-title":"Blood"},{"key":"BFbmt2013111_CR21","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2006-04-019836","volume":"109","author":"PA Carpenter","year":"2007","unstructured":"Carpenter PA, Snyder DS, Flowers ME, Sanders JE, Gooley TA, Martin PJ et al. Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood 2007; 109: 2791\u20132793.","journal-title":"Blood"},{"key":"BFbmt2013111_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2009.011221","volume":"95","author":"JM Ribera","year":"2010","unstructured":"Ribera JM, Oriol A, Gonzalez M, Vidriales B, Brunet S, Esteve J et al. Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica 2010; 95: 87\u201395.","journal-title":"Haematologica"},{"key":"BFbmt2013111_CR23","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/blood-2011-12-399287","volume":"120","author":"N Gokbuget","year":"2012","unstructured":"Gokbuget N, Stanze D, Beck J, Diedrich H, Horst HA, Huttmann A et al. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors and realization of stem cell transplantation. Blood 2012; 120: 2032\u20132041.","journal-title":"Blood"},{"key":"BFbmt2013111_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbmt.2003.11.003","volume":"10","author":"EF Posthuma","year":"2004","unstructured":"Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW et al. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 204\u2013212.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2013111_CR25","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1182\/blood-2008-10-184093","volume":"113","author":"V Bachanova","year":"2009","unstructured":"Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ . Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation. Blood 2009; 113: 2902\u20132905.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/bmt.2013.184","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2013111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2013111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2013111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:13:01Z","timestamp":1648037581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2013111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,12]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFbmt2013111"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2013.111","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,12]]},"assertion":[{"value":"9 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2014","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been corrected since Online Publication and a corrigendum has also been published.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}